Results

Total Results: 515 records

Showing results for "renal".

141. Gout Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Both colchicine and NSAIDs require dose reduction in renal impairment. … Allopurinol treatment and its effect on renal function in gout: a controlled study. … Description and guidelines for prevention in patients with renal insufficiency. … Allopurinol-induced severe hypersensitivity with acute renal failure. … Allopurinol, erythema multiforme, and renal insufficiency. BMJ. 1996 Jan 20;312(7024):173-4.

142. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-update-2015/research-protocol
     December 01, 2019 - The inclusion of the safety outcomes of impaired renal function, urinary tract infections, genital mycotic … 2 A meta-analysis published in 2013, 18 and data from pivotal trials 19,20 have suggested that renal … least one of the following comorbid conditions: End-stage liver disease or cirrhosis End-stage renal … Inclusion criteria Exclusion criteria ESLD = end-stage liver disease; ESRD = end-stage renal … include studies addressing the following safety outcomes for KQ3: Liver injury ^ Impaired renal

143. EHC Protocol: Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
     September 24, 2024 - Patient-centered health outcomes: Incident symptomatic stones, urinary tract obstruction with acute renal … KQ 3, 3a, 3b, 4, 4a, 4b: Followup imaging when used for routine surveillance (CT scan, renal ultrasound … impairment, end-stage renal disease, urinary tract infection, stone-removal procedures/surgery, procedure … NICE Guideline - Renal and ureteric stones: assessment and management. … stone”[tw] OR “renal stones”[tw] OR “renal calcul*”[tw] OR  “staghorn calculi”[tw] OR “staghorn calculus

144. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Nosocomial Pneumonia | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/pneumonia-antibiotic-treatment/research-protocol
     December 01, 2019 - dosing, concurrent nephrotoxic drugs, or prolonged courses of therapy and or in patients with unstable renal … empiric antibiotic-dosing regimens are based on data from noncritically ill patients (with or without renal … with new data derived from patients with HAP, including those who are critically ill with or without renal … Based on public comments, we have added renal dysfunction as a subgroup in KQ 3. … Roberts DM, Roberts JA, Roberts MS, et al; RENAL Replacement Therapy Study Investigators.

145. pneumonia-antibiotic-treatment-protocol-130718 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
     July 19, 2013 - empiric antibiotic-dosing regimens are based on data from noncritically ill patients (with or without renal … with new data derived from patients with HAP, including those who are critically ill with or without renal … Based on public comments, we have added renal dysfunction as a subgroup in KQ 3. … Subgroups:   • HAP, VAP, and HCAP • Immunocompromised • Age, sex, race, and ethnicity • Renal … Roberts DM, Roberts JA, Roberts MS, et al; RENAL Replacement Therapy Study Investigators.

146. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/stroke-afib-update/research-protocol
     September 01, 2019 - The HAS-BLED (H=hypertension, A=abnormal renal/liver function, S=stroke, B=bleeding history or predisposition … inhibitor; DVT = deep vein thrombosis; eGFR = estimated glomerular filtration rate; ESRD = end-stage renal … , labile INR, elderly (> 65), drugs/alcohol concomitantly; HEMORR2HAGES = hepatic or renal disease, ethanol … failure"[tiab] OR "end stage renal disease"[tiab] OR ESRD[tiab] OR “end stage kidney disease”[tiab] … OR ESKD[tiab] OR “renal function”[tiab] OR diabetes[tiab] OR diabetic[tiab] OR sex[tiab] OR race[tiab

147. Kidney-Stone-Prevention Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
     March 01, 2013 - Renal stone epidemiology in Rochester, Minnesota: an update. … Kairaitis L, Caring for Australians with Renal I. The CARI guidelines. … Becker G, Caring for Australians with Renal I. The CARI guidelines. Kidney stones: cystine stones. … Becker G, Caring for Australians with Renal I. The CARI guidelines. … Placebo versus allopurinol for renal calculi. Journal of Urology. 1977 Jun;117(6):690-2.

148. Bladder-Cancer-Muscle-Invasive Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
     June 01, 2015 - Therefore, factors such as performance status and renal function must be considered in relation to treatment … For example, medically frail patients with baseline renal insufficiency may not be ideal candidates … for cisplatin-based therapy because of potential renal toxicity. … Although cisplatin is nephrotoxic, renal adverse events were not well reported.28 No study compared … For patients with renal dysfunction, carboplatin may be considered because it is less nephrotoxic than

149. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Advances in antihypertensive therapy have dramatically reduced cardiovascular, cerebrovascular, and renal … intake on ACEI/ARB/DRI effectiveness or harms . 3 The impact of ACEI/ARB/DRI on progression of renal … Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes … There appears to be a small difference in change in renal function between ACE inhibitors and ARBs ( … Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2

150. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
     May 02, 2011 - marrow plasma cells ≤10%  Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … urinary monoclonal protein  Evidence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … marrow plasma cells ≥10%  Absence of end-organ damage (bone lesions, anemia, hypercalcemia, or renal … end-organ damage, including skeletal destruction (lytic bone lesions), hypercalcemia, anemia, and renal … This ratio remains normal in polyclonal hypergammaglobulinemia or in renal insufficiency where free

151. Fourth Symposium on Comparative Effectiveness Research Methods: From Efficacy to Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cer-methods-4th-symposium/overview
     November 01, 2018 - estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal … estimate different parameters of the effect of erythropoietin stimulating agents on survival in end stage renal

152. Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/kidney-stones/protocol
     December 01, 2024 - Patient-centered health outcomes: Incident symptomatic stones, urinary tract obstruction with acute renal … KQ 3, 3a, 3b, 4, 4a, 4b: Followup imaging when used for routine surveillance (CT scan, renal ultrasound … Patient-centered health outcomes: Incident symptomatic stones, urinary tract obstruction with acute renal … NICE Guideline - Renal and ureteric stones: assessment and management. … stone”[tw] OR “renal stones”[tw] OR “renal calcul*”[tw] OR  “staghorn calculi”[tw] OR “staghorn calculus

153. Santa_ECCS2012 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/santa_eccs2012.pdf
     February 01, 2013 - Plain-­‐language versions of selected topics • Longer “stories” about more complex topics: chronic renal … Cancer (American Society of Clinical Oncology): “Even in cancer, more may not be better.” • Chronic  renal … failure (American Society of Nephrology): “Even in chronic renal disease, more treatment may not be

154. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - • The inclusion of the safety outcomes of impaired renal function, urinary tract infections, genital … side effects; and for comparisons including SGLT-2 inhibitors, urinary tract infections, impaired renal … side effects; and for comparisons including SGLT-2 inhibitors, urinary tract infections, impaired renal … one of the following comorbid conditions: • End-stage liver disease or cirrhosis • End-stage renal … include studies addressing the following safety outcomes for KQ3: § Liver injury^ § Impaired renal

155. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0430_04-22-2011.pdf
     January 01, 2011 - recatheterization, prevention of urinary tract infections, improved quality of life, potential harms (infection, renal

156. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1
     December 01, 2019 - Effects on Chronic Disease Outcomes and Risks Systematic Review ARCHIVED Aug 16, 2016 Renal

157. Contrast-Induced Nephropathy | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/nephropathy-contrast-induced/research
     January 01, 2020 - studies that investigated IOCM versus LOCM, the outcomes of mortality, cardiovascular outcomes, need for renal … bicarbonate, and statins, among others) to reduce the risk of contrast-induced nephropathy (CIN), need for renal

158. Data Points #1: Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006-2008. | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-foot-ulcer-amputation-prevalence/research
     December 01, 2019 - Those with diabetes are expected to suffer from several associated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease

159. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
     September 29, 2011 - each treatment strategy (i.e., adverse drug reactions, radiation exposure, access site complications, renal … effects of intervention(s): Adverse drug reactions, radiation exposure, access site complications, renal … life Cognitive effects Adverse drug reactions, radiation exposure, access site complications, renal … adverse effects, including adverse drug reactions, radiation exposure, access-site complications, renal … adverse events, including adverse drug reactions, radiation exposure, access-site complications, renal

160. Kidney Failure | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/kidney-failure
     June 13, 2013 - Research Protocol Archived June 13, 2013 Troponin Cardiac Marker Interpretation During Renal